These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36153243)

  • 41. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic Acid copolymer: preliminary results.
    Puri P; Chertin B; Velayudham M; Dass L; Colhoun E
    J Urol; 2003 Oct; 170(4 Pt 2):1541-4; discussion 1544. PubMed ID: 14501655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical value of persistent but downgraded vesicoureteral reflux after dextranomer/hyaluronic acid injection in children.
    Baek M; Kang MY; Lee HE; Park K; Choi H
    J Korean Med Sci; 2013 Jul; 28(7):1060-4. PubMed ID: 23853490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer is effective in either double ureters or a small kidney.
    Läckgren G; Wåhlin N; Sköldenberg E; Nevéus T; Stenberg A
    J Urol; 2003 Oct; 170(4 Pt 2):1551-5; discussion 1555. PubMed ID: 14501658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy.
    Jung C; DeMarco RT; Lowrance WT; Pope JC; Adams MC; Dietrich MS; Brock JW
    J Urol; 2007 Jan; 177(1):312-5. PubMed ID: 17162075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the double hydrodistention implantation technique (HIT) and the HIT with a polyacrylate/polyalcohol copolymer (PPC) for the endoscopic treatment of primary vesicoureteral reflux.
    Akin M; Erginel B; Karadag CA; Yildiz A; Ozçelik GS; Sever N; Genc NM; Dokucu AI
    Int Urol Nephrol; 2014 Nov; 46(11):2057-61. PubMed ID: 24966099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux.
    Kobelt G; Canning DA; Hensle TW; Läckgren G
    J Urol; 2003 Apr; 169(4):1480-4; discdussion 1484-5. PubMed ID: 12629396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endoscopic correction of vesicoureteral reflux in children using polyacrylate-polyalcohol copolymer (Vantris): 5-years of prospective follow-up.
    Warchoł S; Krzemień G; Szmigielska A; Bombiński P; Toth K; Dudek-Warchoł T
    Cent European J Urol; 2017; 70(3):314-319. PubMed ID: 29104797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study.
    Stenbäck A; Olafsdottir T; Sköldenberg E; Barker G; Stenberg A; Läckgren G
    J Pediatr Urol; 2020 Jun; 16(3):328.e1-328.e9. PubMed ID: 32414615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
    Hunziker M; Mohanan N; Puri P
    J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon.
    Hsieh MH; Madden-Fuentes RJ; Lindsay NE; Roth DR
    Urology; 2010 Jul; 76(1):199-203. PubMed ID: 20035980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter.
    Kirsch AJ; Perez-Brayfield M; Smith EA; Scherz HC
    J Urol; 2004 Jun; 171(6 Pt 1):2413-6. PubMed ID: 15126864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of concomitant autologous blood and dextranomer/hyaluronic acid copolymer injection to correct vesicoureteral reflux.
    Kajbafzadeh AM; Tourchi A
    J Urol; 2012 Sep; 188(3):948-52. PubMed ID: 22819104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long-term results.
    Garcia-Aparicio L; Rovira J; Blazquez-Gomez E; García-García L; Giménez-Llort A; Rodo J; Morales L
    J Pediatr Urol; 2013 Aug; 9(4):483-7. PubMed ID: 23602843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.
    Puri P; Kutasy B; Colhoun E; Hunziker M
    J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent trends in the surgical management of primary vesicoureteral reflux in the era of dextranomer/hyaluronic acid.
    Herbst KW; Corbett ST; Lendvay TS; Caldamone AA
    J Urol; 2014 May; 191(5 Suppl):1628-33. PubMed ID: 24679885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management.
    Benoit RM; Peele PB; Docimo SG
    J Urol; 2006 Oct; 176(4 Pt 1):1588-92; discussion 1592. PubMed ID: 16952694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term followup after endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer in patients with neurogenic bladder.
    Polackwich AS; Skoog SJ; Austin JC
    J Urol; 2012 Oct; 188(4 Suppl):1511-5. PubMed ID: 22910250
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interventions for primary vesicoureteric reflux.
    Williams G; Hodson EM; Craig JC
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD001532. PubMed ID: 30784039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection.
    Routh JC; Reinberg Y; Ashley RA; Inman BA; Wolpert JJ; Vandersteen DR; Husmann DA; Kramer SA
    J Urol; 2007 Oct; 178(4 Pt 2):1702-5; discussion 1705-6. PubMed ID: 17707019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subureteral Injection with Small-Size Dextranomer/Hyaluronic Acid Copolymer: Is It Really Efficient?
    Üre I; Gürocak S; Tan Ö; Farahvash A; Senol C; Gümüstas H; Atay I; Deniz N
    Biomed Res Int; 2016; 2016():2168753. PubMed ID: 28105412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.